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Abstract
Tetracycline or doxycycline (dox)-regulated control of genetic elements allows inducible, reversible and tissue specific
regulation of gene expression in mice. This approach provides a means to investigate protein function in specific cell
lineages and at defined periods of development and disease. Efficient and stable regulation of cDNAs or non-coding
elements (e.g. shRNAs) downstream of the tetracycline-regulated element (TRE) requires the robust expression of a tet-
transactivator protein, commonly the reverse tet-transactivator, rtTA. Most rtTA strains rely on tissue specific promoters that
often do not provide sufficient rtTA levels for optimal inducible expression. Here we describe the generation of two mouse
strains that enable Cre-dependent, robust expression of rtTA3, providing tissue-restricted and consistent induction of TRE-
controlled transgenes. We show that these transgenic strains can be effectively combined with established mouse models
of disease, including both Cre/LoxP-based approaches and non Cre-dependent disease models. The integration of these
new tools with established mouse models promises the development of more flexible genetic systems to uncover the
mechanisms of development and disease pathogenesis.
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Introduction
Genetically engineered mouse models (GEMMs) are an
invaluable tool to investigate the biology of development and
disease in a mammalian organism. Since the development of the
first knockout mouse almost 25 years ago, a wide variety of
knockout, knock-in and conditional mutant strains have been
developed to interrogate gene function [1]. In recent years, use of
inducible promoters to control genetic elements in adult mice has
become increasingly valuable, allowing regulated control of
cDNAs and, more recently, shRNAs. In concept, these systems
enable the timed expression or silencing of any gene, in any tissue
and at any stage of development or disease progression. The
application of such experimental tools promises a detailed
understanding of the temporal requirements for gene function in
specific tissues and provides an opportunity to genetically validate
proposed therapeutic targets prior to drug development.
The tetracycline (tet) system is, by far, the most widely used
inducible model in mice. It consists of two essential components: a
tetracycline-responsive element (TRE) that regulates gene or
shRNA expression, and a trans-acting, tet-sensitive, tet-transacti-
vator (tTA) or reverse tet-transactivator (rtTA) protein [2]. tTA
promotes gene expression from TRE promoters, but is inhibited in
the presence of tet, or its more common analog, doxycycline (dox).
Conversely, rtTA promotes dox-dependent gene induction. Early
versions of the rtTA protein showed ‘leaky’ gene expression in the
absence of dox, but newer variants such as rtTAM2 and rtTA3
[3,4] show almost no dox-independent activity, and in the case of
rtTA3, high sensitivity to low levels of dox. To date, more than
150 tTA/rtTA transgenic and knock-in strains have been
developed to enable regulated gene expression in embryonic and
adult tissues (http://www.tetsystems.com/fileadmin/
tettransgenicrodents.pdf). As expression of the TRE-regulated
cassette is dependent on both the presence of tet-transactivator
and dox, induction can be ubiquitous or tissue specific (by
controlling tTA/rtTA expression), inducible and reversible (by
controlling dox exposure). Tissue specific TRE gene regulation is
usually achieved by restricting the expression of tTA or rtTA to
defined cell lineages using a tissue-specific promoter. Though
convenient, this approach is absolutely dependent on robust
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expression of the tTA/rtTA. Moreover, cellular response down-
stream of transgene/shRNA induction may alter cell fate and
compromise sustained TRE-regulated control. We recently
described a new reverse tet-transactivator strain, CAGs-rtTA3, that
shows stronger and more ubiquitous induction of TRE-regulated
elements than any other existing strains we have tested [5]. Here
we set out to develop a more flexible transgenic approach
exploiting the strength of TRE-induction seen with CAGs-rtTA3
and enabling tissue specific TRE-regulation.
Results
Conditional rtTA3 ES cell lines
Conditional gene modification in mice is most commonly
achieved using tissue specific Cre recombinase strains and
hundreds of such mice have already been developed and tested;
More than 300 Cre strains are available from the Jackson
Laboratory. We reasoned that Cre-dependent expression of rtTA3
from the CAGs promoter would enable robust and tissue-specific
TRE-transgene induction in almost any cell lineage. Thus, we
modified our CAGs-rtTA3 construct to contain a LoxP-flanked
polyadenylation signal or LoxP-Stop-LoxP (LSL) cassette (CAGs-
LSL-rtTA3). In addition, we cloned a variant that also carried the
mKate2 far-red fluorescent gene [6] downstream of an Internal
ribosomal entry site (IRES) (CAGs-LSL-rtTA3-IRES-mKate2 – CAGs-
LSL-RIK) (Fig. 1A). In this context, mKate2 fluorescence serves as
a reporter of Cre recombinase activity and rtTA3 expression. We
cloned each construct into the pRosa26-1 targeting backbone and
transfected C10 ES cells [7]. Southern blot analysis of puromycin-
selected clones identified correctly targeted clones for each
construct (Fig. S1). In the case of CAGs-LSL-RIK, we identified
one clone (designated D34), which showed homozygous targeting
to the Rosa26 locus. We further confirmed targeting on both copies
of chromosome 6 in this ESC line by fluorescence in-situ
hybridization (FISH) (Fig. S1C) and later, by breeding founder
animals, which transmitted the allele to 100% of their progeny (not
shown).
We first sought to confirm that both the CAGs-LSL-rtTA3
(designated Y1) and CAGs-LSL-RIK (D34) cells showed robust
expression of rtTA3 protein and therefore strong induction of
TRE-regulated transgenes. To do this we took advantage of a
recombinase-mediated cassette exchange (RMCE) ‘landing pad’
downstream of the col1a1 locus in C10 ESCs [7]. This knock-in
cassette allows efficient targeting of TRE-regulated (and other)
transgenes, including cDNAs [8] and shRNAs [5]. We transfected
Y1 and D34 cells with a col1a1 RMCE targeting vector we
previously described that expresses GFP and an shRNA directed
against Renilla luciferase (Ren.713) downstream of TRE (TG-
Ren.713). Throughout this study we use the TG-Ren.713 transgene
as a neutral fluorescent marker of dox-mediated induction.
Following hygromycin selection, individual clones were expanded
and transduced with a limiting titer of adenovirus expressing Cre
recombinase to achieve recombination in 10–25% of cells. As
expected, adenovirus transduced cells treated with doxycycline
showed strong induction of GFP (Fig. S2). To confirm that single
Cre-recombined clones showed uniform GFP induction we plated
adenoviral treated Y1 cells at low density and isolated individual
clones. 2/24 clones picked showed consistent and uniform, dox-
dependent induction of GFP, whereas untreated cells showed no
detectable GFP signal by flow cytometry (Fig. 1B).
To confirm the quality of Y1 and D34 ESCs for animal
production, we generated wholly ESC-derived mice by tetraploid
embryo complementation and bred multiple founder animals.
Each cell line produced numerous viable and fertile mice that
showed expected Mendelian transmission of the Rosa26-targeted
allele (Table 1). Moreover, we also generated mice from both lines
following col1a1 re-targeting by RMCE (not shown), demonstrat-
ing that both Y1 and D34 are robust ESC lines that can serve as a
platform for the production of conditional, TRE-inducible mice
for analysis.
CAGs-rtTA3 and CAGs-RIK enable robust and widespread
TRE-induction in vivo
We have previously noted that limited expression of rtTA from
the endogenous Rosa26 promoter (R26-rtTA) results in restricted
induction of TRE-driven GFP in adult mouse tissues [5]. To test
TRE-mediated induction from CAGs-rtTA3 transgenes targeted to
the Rosa26 locus, we crossed each strain to a CAGs-Cre ‘deletor’
mouse that induces LoxP recombination at or before the two-cell
stage [9]. Excision of the LSL cassette in the F1 progeny from each
strain was confirmed by PCR and each of the recombined alleles
could be propagated through breeding at Mendelian ratios,
indicating there was no appreciable toxicity from the CAGs-driven
expression of rtTA3 or mKate2 in vivo (Table 1).
We next bred CAGs-rtTA3 and CAGs-RIK mice to TG-Ren.713
mice generated previously [5], allowing GFP fluorescence to serve
as a neutral marker of TRE induction. Similar to what was
observed in our transgenic CAGs-rtTA3 strain, Rosa26-targeted
CAGs-rtTA3 and CAGs-RIK enabled robust TRE-driven GFP
expression in most tissues, including both solid organs and
hematopoietic cells (Figs. 2, 3, 4 and Fig. S3). CAGs-rtTA3 and
CAGs-RIK showed significantly higher GFP induction in skin, liver,
kidney, pancreas, compared to R26-rtTA (Fig. 2), while all animals
showed high-level induction in intestine and T cells (Figs. 3A and
4), as previously reported [5,10]. Immunofluorescent staining for
GFP and mKate2 revealed uniform and consistent staining in
multiple cell types in each organ analyzed, compared to R26-rtTA
that often showed absent or patchy expression in organs including
pancreas and liver (Fig. 3B, Fig. S3B). As expected, CAGs-RIK
mice showed uniform expression of mKate2 in all tissues
examined. Interestingly, splenic B cells showed poor induction of
the TRE-GFP transgene in all rtTA strains analyzed, including
CAGs-RIK, despite relatively uniform mKate2. As mKate2 is
expressed from the same polycistronic transcript as rtTA3, it is
likely that these cells, which fail to induce high levels of GFP,
contain abundant rtTA3 protein. To confirm this, we sorted
mKate2+/GFPdim and mKate2+/GFPhi splenic cells from CAGs-
RIK/+;TG-Ren.713/+ mice treated with dox for one week, and
assayed rtTA3 expression. Both QPCR and western blot analysis
showed comparable levels of rtTA3 mRNA and protein in GFPhi
and GFPdim cells (Fig. 4C,D), implying that the failure to induce
GFP in some mKate2 positive cells is not due to reduced or absent
rtTA3 expression, in contrast to previous observations with an
independent CAGs-rtTA3 strain [10]. Although the mechanism
underlying this observation is not known, it is possible that the
col1a1-targeted, TRE-driven transgene is silenced or inaccessible in
some cell types.
Importantly, both CAGs-driven strains showed almost identical
GFP expression indicating that the presence of mKate2 in the
CAGs-RIK strain did not alter rtTA3 levels. Together this data
confirms that the CAGs promoter (at the Rosa26 locus) can drive
strong and widespread expression of rtTA3, allowing dox-
dependent TRE induction in almost all tissues. Importantly, this
implies that in combination with an appropriate Cre driver, both
CAGs-LSL-rtTA3 and CAGs-LSL-RIK strains can provide robust,
tissue and/or cell-type specific TRE-mediated gene expression.
New Cre-Dependent rtTA Mouse Strains
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e95236
Mosaic TRE-induction through adenoviral Cre delivery
Tissue restricted Cre recombinase expression can be achieved in
mice through the delivery of virus (adeno- or lentivirus) to specific
organs. Intravenous (tail-vein) injection of adenovirus results in
almost exclusive transduction of liver hepatocytes. As a first step to
evaluate Cre-mediated, tissue specific TRE-induction we injected
CAGs-LSL-rtTA3 and CAGs-LSL-RIK mice (also carrying TG-
Ren.713) with Adenoviral-Cre (AdenoCre) and treated mice with
dox for one week. As expected, AdenoCre, dox-treated CAGs-LSL-
rtTA3 and CAGs-LSL-RIK mice showed mosaic expression of GFP
(and mKate2 in CAGs-LSL-RIK animals) in the liver (Fig. 5A).
Importantly, we have never observed GFP signal in the absence of
mKate2, suggesting mKate2 is a reliable indicator of rtTA3
expression, and no GFP was detected in any of the organs from
dox-treated animals that were not exposed to Cre, indicating very
low or no leaky expression of the rtTA3 transgene in adult mice.
Restricted delivery of AdenoCre to the mouse trachea allows
mosaic Cre-mediated recombination in the lung epithelium [11].
We have previously shown that the Clara-cell Secretory Protein
(CCSP)-rtTA transgenic strain can drive lung-specific expression
of GFP-linked shRNAs in combination with AdenoCre-induced
KrasG12D [5]. To assess whether our Cre-dependent rtTA3 alleles
Figure 1. Generation of CAGs-LSL-rtTA3 and CAGs-LSL-RIK strains. A. Schematic representation of CAGs-LSL-rtTA3 and CAGs-LSL-rtTA3-IRES-
mKate2 (RIK) alleles targeted to the Rosa26 locus, prior to and following Cre-mediated recombination. B. Correctly targeted CAGs-LSL-rtTA3 ESCs (Y1),
were retargeted by recombinase mediated cassette exchange (RMCE) to introduce a TRE-GFP-miR30 (TGM) construct to the col1a1 recipient locus.
Targeted cells were transduced with adenovirus expressing Cre and plated at low density to isolate individual clones. Clones were treated with
doxycycline (1 ug/ml) for 2 days and analyzed by flow cytometry. Graph represents GFP fluorescence of TGM containing, dox-treated CAGs-LSL-rtTA3
(black line) and recombined CAGs-rtTA3 (green line) clones.
doi:10.1371/journal.pone.0095236.g001
Table 1. Mendelian transmission of Rosa26-targted CAGs-rtTA3 transgenes.
Genotype CAGs-LSL-rtTA3 CAGs-rtTA3 CAGs-LSL-RIK CAGs-RIK
Transgene 219 (217)* 110 (124) 84 (85) 130 (137.5)
Wildtype 215 (217) 138 (124) 86 (85) 145 (137.5)
p-value (two-tail, binomial test) 0.89 0.09 0.94 0.40
*Numbers represent: observed (expected) from heterzygote x wild-type crosses.
doi:10.1371/journal.pone.0095236.t001
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would similarly allow dox-dependent shRNA induction in
KrasG12D expressing lung epithelium we treated LSL-KrasG12D/+;
TG-Ren.713/+;CAGs-LSL-RIK/+ mice with AdenoCre (56106
PFU) via intratracheal injection and treated with dox for one week
prior to analysis. Three months following AdenoCre treatment
animals showed small KrasG12D-driven adenomas throughout the
lung epithelium (Fig. 5B, Fig. S4) consistent with previous reports
[12]. In almost all cases, KrasG12D-driven adenomas were GFP
and mKate2 positive, indicating strong expression of rtTA3 and
TRE-regulated shRNAs in these lesions. We observed only a very
small proportion of individual mKate2 positive cells that did not
express GFP (Fig. 5B, white arrows). In addition, in some lesions
we noted some small areas of adenomas that were mKate2
negative (Fig. S4), implying activation of LSL-KrasG12D without
CAGs-LSL-RIK recombination. It was not possible to determine
whether there were also cases of CAGs-LSL-RIK recombination
without KrasG12D activation, as these events would not expand
into adenomas. In all, this work demonstrates that both CAGs-LSL-
rtTA3 and CAGs-LSL-RIK allow robust and tissue-specific expres-
sion of rtTA3 in adult mice following restricted Cre exposure.
Tissue specific TRE-induction in transgenic Cre tumor
models
In principle, integration of the Cre-conditional rtTA approach
described above into existing disease models would enable a more
precise investigation of gene function in complex genetic
backgrounds. To test this we incorporated the CAGs-LSL-RIK into
two well-established models, specifically, a Cre-dependent, LSL-
KrasG12D-driven pancreatic cancer model [13] and Cre-indepen-
dent, MMTV-ErbB2 driven mammary cancer model [14].
Kras (codon 12 or 13) mutation is considered an initiating and
driving event in most pancreatic ductal adenocarcinomas. In the
Figure 2. CAGs-rtTA3 and CAGs-RIK show strong expression in adult tissues. Whole mount epifluorescence images of small intestine, skin,
pancreas kidney and liver from R26-rtTA, CAGs-rtTA3 and CAGs-RIK transgenic animals (all containing TG-Ren.713). R26-rtTA shows strong expression in
intestine and skin but weak or patchy expression in most other solid organs. CAGs-rtTA3 and CAGs-RIK show almost identical expression patterns in
adult mice. CAGs-RIK mice show strong and consistent expression of mKate2.
doi:10.1371/journal.pone.0095236.g002
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mouse, pancreatic restricted expression of KrasG12D, via a
pancreas specific Cre such as Pdx1-Cre, leads to preneoplastic
PanIN lesions [13]. We generated quadruple transgenic mice
carrying LSL-KrasG12D/+;Pdx1-Cre/+;CAGs-LSL-RIK/+;TG-
Ren.713/+ and treated them with doxycycline until 3 months of
age. At this time the pancreas showed mosaic expression of
mKate2 and GFP due to mosaic expression of the Pdx1-Cre allele.
As expected, histology of the pancreas in 3-month old transgenic
animals showed both normal acinar tissue and the development of
acinar-to-ductal metaplasia and early PanIN lesions, as previously
described [13]. The majority of PanIN lesions showed strong GFP
and mKate2 expression confirming robust induction of rtTA3 and
the GFP-linked shRNA. As noted following AdenoCre treatment
in the lung, we observed some small regions of ADM/PanIN
lesions that did not express mKate2 or GFP (Fig. 6A, white
arrows). We have now used the combination of Cre-driven
pancreatic lesions with inducible shRNAs to investigate the genetic
requirements underlying the initiation and progression of Kras-
driven pancreas cancer [15].
Overexpression of HER2/Neu (encoded by the ERBB2 gene) is
a common feature of human breast cancer. In the mouse, this
event can be mimicked via expression of a mutant rat ortholog
neuV664E allele downstream of a mouse mammary tumor virus
(MMTV) promoter [14]. The MMTV-neuV664E model has been
used extensively to investigate the genetics and physiology of
breast cancer progression. Expression of neuV664E in this model is
not dependent on the activity of Cre recombinase, therefore we
asked whether our Cre-dependent CAGs-LSL-RIK allele could be
used effectively in combination with MMTV-neuV664E to express
inducible shRNAs in the mammary gland and drive tumorigen-
Figure 3. GFP induction and mKate2 expression is uniform in most organs of CAGs-rtTA3 and CAGs-RIKmice. Immunofluorescence stains
for GFP and mKate2 in the small intestine and pancreas of ‘no rtTA’, R26-rtTA, CAGs-rtTA3 and CAGs-RIK mice following 1 week of doxycycline
treatment. All rtTA strains show strong GFP induction in small intestine (A), but only CAGs-rtTA3 and CAGs-RIK show robust and uniform GFP
expression (and mKate2 for RIK) in the pancreatic acinar tissue (B).
doi:10.1371/journal.pone.0095236.g003
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esis. For this, we generated female MMTV-neuV664E/+;CAGs-LSL-
RIK/+;TG-Ren.713/+ animals also carrying the murine whey acidic
protein gene promoter (WAP)-driven Cre transgene which responds
to lactogenic hormones [16]. Parous females nursed litters for 3
weeks to induce expression of WAP-Cre and were treated with
doxycycline to induce shRNA expression. These mice showed
luminal epithelial expression of mKate2 and GFP (Fig. 6B, top
panel), and developed neuV664E-driven GFP and mKate2 positive
Figure 4. CAGs-rtTA3 and CAGs-RIK enable GFP induction in myeloid and T lymphocyte lineages. A. Scatter plots representing GFP and
mKate2 expression in Gr1 positive cells in the bone marrow of double transgenic (rtTA/TGM) animals following 1 week of doxycycline treatment
(625 mg/kg in chow). B. Quantitation of GFP and mKate2 positive cells in Gr1, Thy1 and CD19 positive populations from the bone marrow, thymus
and spleen respectively. Bars represent the mean percentage of GFP or mKate2 positive cells in each tissue, in 3 independent animals (per genotype)
+/2 SEM. C. Western blot of lysates from control (c57Bl/6), GFP negative and GFP positive splenocytes, indicating rtTA3, GFP and mKate2 expression
in each population. Retrovirally transduced 3T3 cells serve as the positive control for rtTA3 expression. D. Graphs represent mRNA abundance in
control (C57Bl/6), GFP negative and GFP positive splenocytes.
doi:10.1371/journal.pone.0095236.g004
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tumors at a median latency of approximately 160 days post
partum (Fig. 6B, lower panel). Although not all tumors from TG-
Ren.713 mice showed mKate2/GFP expression due to an
incomplete overlap of expression between the MMTV and WAP
promoters, this novel multi-allelic system has proven a powerful
platform for the study of tumor suppressor gene function in the
context of HER2-driven breast cancer (SHE and SWL, unpublished
data).
Discussion
Spatial and temporal control of gene expression provides a
means to understand the contribution of genetic disruptions to
disease progression and offers a setting to interrogate the role of
individual genes in disease maintenance. Here we describe the
generation and characterization of two novel ESC lines and mouse
strains that enable Cre-dependent, robust expression of the reverse
tet-transactivator (rtTA3) and thus, tissue-restricted induction of
TRE-controlled transgenes. Further, we show that these trans-
genic strains can be effectively combined with established mouse
models of disease, including Cre/LoxP-based approaches and
Cre-independent model systems. The integration of established
models of disease with the flexibility of inducible and reversible
gene regulation will allow a more detailed interrogation of the
underpinnings of disease pathogenesis and evolution. For instance,
model systems that incorporate constitutive and inducible genetic
alterations with inducible and reversible gene silencing (or
overexpression) offer the unique opportunity to investigate how
the temporal order of events determines disease progression and
whether those events are required for disease maintenance. Such
Figure 5. Adenoviral Cre induces mosaic activation of rtTA and GFP induction in CAGs-LSL-rtTA3 and CAGs-LSL-RIK animals. A.
Immunofluorescent stains for GFP and mKate2 in liver sections of TG-Ren.713;CAGs-LSL-rtTA3 and TG-Ren.713;CAGs-LSL-RIK mice 1 week following
intravenous injection of Adenoviral Cre (56108 PFU) or PBS (CAGs-LSL-RIK only – left panel) and dox treatment. Double transgenic mice exposed to
AdenoCre show mosaic expression of GFP (CAGs-LSL-rtTA3) or GFP and mKate2 (CAGs-LSL-RIK). No GFP of mKate2 expression was observed in animals
not exposed to Cre. B. Immunofluorescent stains for GFP and mKate2 in lung sections of triple transgenic mice (CAGs-LSL-rtTA3 or RIK;TG-Ren.713;LSL-
KrasG12D). KrasG12D-induced lung adenomas show strong expression of GFP and mKate2. Lowe panel: higher magnification of the lesion. White arrows
indicate rare cells that show mKate2, but not GFP expression.
doi:10.1371/journal.pone.0095236.g005
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work will ultimately lead to better understanding of disease and the
development of more accurate and effective preclinical models.
In contrast to strategies that rely on tet-transactivators driven by
tissue specific promoters (http://www.tetsystems.com/fileadmin/
tettransgenicrodents.pdf) our approach integrates the use of
established tissue-restricted Cre recombinase strains to initiate
TRE induction. Previous studies have reported the generation of
Cre-dependent tTA and rtTA strains driven by the endogenous
Rosa26 promoter [17–19]. We have previously shown that Rosa26
promoter activity can vary significantly in different tissues of adult
mice, resulting in sub-optimal TRE induction in a range of cell
types [5]. In contrast, the synthetic, ubiquitous CAGs promoter
provides robust TRE induction in most adult tissues (Fig. 2). Thus,
given an appropriate Cre driver, CAGs-LSL-rtTA3 and CAGs-LSL-
RIK provide potent, doxycycline-dependent transgene/shRNA
expression in most tissues accessible to doxycycline. In addition, as
the CAGs promoter drives robust expression of rtTA3 in many
different cell lineages and at different stages of differentiation,
CAGs-LSL-rtTA3 strains offer a significant advantage over tTA/
rtTA strains that depend on lineage specific promoters, such as
those expressed only in stem or progenitor cells. In this regard, we
have observed that transient induction of Cre recombinase activity
in stem cells of the intestine using Lgr5-GFP-IRES-CreER, promotes
long-lived rtTA3 expression (and GFP induction) in individual
crypts and villi of the small and large intestine (LED and SWL,
unpublished data).
During our analysis of multi-allelic animals carrying LSL-
KrasG12D and CAGs-LSL-RIK, we noted some areas of tissue that
showed characteristic KrasG12D-induced changes (lung adenomas
or PanINs), which did not show expression of mKate2, suggesting
Cre-induced recombination of only a subset of ‘floxed’ genes in the
genome. Because KrasG12D-driven phenotypes are not 100%
penetrant in either tissue, we have not been able to measure the
frequency of cells that show recombination only at the CAG-LSL-
RIK allele and not KrasG12D. The reasons behind this incomplete
recombination are not clear but may reflect the regions
surrounding the LoxP sites. Of note, we have observed increased
recombination efficiency of the CAGs-LSL-rtTA3 allele compared
Figure 6. CAGs-LSL-RIK enables tissue-restricted expression of TRE-transgenes in transgenic models of disease. A. Whole mount
epifluorescence (top panel) and immunofluorescence images from a quadruple transgenic (CAGs-LSL-RIK;TG-Ren.713;LSL-KrasG12D;Pdx1-Cre) animal,
showing induction of GFP and mKate2 in both normal acinar tissue and pre-neoplastic, KrasG12D-induced PanIN lesions (top arrow). As observed in
AdenoCre treated lungs, some PanIN lesions did not show GFP or mKate2 staining suggesting incomplete LSL excision in a small proportion of cells.
B. Immunofluorescent stains for GFP and mKate2 in mammary tissue of CAGs-LSL-RIK;TG-Ren.713;MMTV-Neu;WAP-Cre transgenic mice treated with
dox.
doi:10.1371/journal.pone.0095236.g006
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to the CAGs-LSL-RIK strain in cases of low or transient Cre
expression; the two alleles vary slightly in sequences close to the 39
LoxP site due to alternate cloning strategies. It is likely that
incomplete LoxP recombination is a feature of many complex, Cre-
dependent models, but it goes undetected due to a lack of reporter-
based approaches. The presence of mKate2 as a Cre reporter in
CAGs-LSL-RIK provides a means to clearly identify cells and tissues
that express rtTA3 and are capable of inducing shRNA or
transgene expression, irrespective of fluorescent tags linked to such
transgenes (e.g. GFP). Thus, it enables tracking and/or prospective
isolation of Cre-recombined cells prior to induction of, and post-
withdrawal of, TRE-driven transgene/shRNA expression.
We and others recently described a conceptually new approach
to complex mouse modeling, based on the derivation and
manipulation of conditional, multi-allelic embryonic stem cells
(ESCs), which we use to generate tailored genetic models for
analysis [1,5,20]. Such ESC-GEMMs provide a means to rapidly
interrogate gene function in genetically complex animal models in
a fraction of the time required for traditional breeding. During the
genesis of the two transgenic strains described here we generated
ESC lines carrying CAGs-LSL-rtTA3 (Y1) or CAGs-LSL-RIK (D34)
as well as the col1a1 homing cassette for RMCE. Thus Y1 and D34
cells could be employed by investigators wanting to fast track
analysis of a gene or genes in a setting where Cre recombinase is
delivered extrinsically (i.e. intratracheal or intravenous injection)
or used as a base ESC line for the introduction of additional
genetic manipulations, such as the incorporation of tissue specific
Cre knock-in alleles. Alternately these alleles could be incorporat-
ed into ESC-GEMMs through re-derivation of new ESC lines. In
fact, we have recently validated the use of this approach by
producing a number of KrasG12D-based pancreatic cancer models,
using CAGs-LSL-RIK to drive pancreas-specific expression of
positive and negative regulators of tumor initiation and progres-
sion [15].
Together, the ESCs and mouse strains described here bolster
the already impressive arsenal of in vivo, tet-based systems for
manipulation of gene expression by providing robust tools for
tissue-restricted induction of transgenes and shRNAs. Integrating
these new strains with existing mouse modeling platforms promises
to provide a wealth of new discoveries by unearthing the details of
gene function in all stages of development and throughout the
pathogenesis of disease.
Materials and Methods
ES cell targeting
All ES cells were maintained on irradiated feeders in M15
media containing LIF as previously outlined [21]. Targeting
vectors were linearized using a unique PmeI site introduced
downstream of the Diphtheria Toxin A (DTA) expression cassette.
C2 ES cells (16107) were electroporated with 50 ug linearized
targeting vector using a BioRad Gene Pulser and plated in M15
media as previously described [21]. Two days following transfec-
tions cells were treated with media containing 1 ug/ml puromycin
and individual surviving clones were picked after 9–10 days of
selection. Two days after clones were picked puromycin was
removed from the media and cells were cultures in standard M15
thereafter. For Southern blots, genomic DNA from individual ES
cell clones was digested overnight in either EcoRI or EcoRV/BglII
(See Fig. S1).
Animal husbandry
ES cell-derived mice were produced by tetraploid complemen-
tation as has been described elsewhere (Zhao, Nat Prot 2010). For
removal of the ‘LSL cassette’ in vivo, CAGs-LSL-rtTA3 and CAGs-
LSL-RIK (R26Sortm1(CAGs-LSL-rtTA3)Slo and R26Sortm2(CAGs-LSL-RIK)Slo)
mice were crossed to the CAGs-Cre transgenic strain and F1
progeny were genotyped for LoxP recombination using specific
primers (see Table S1). TG-Ren.713 [5], WAP-Cre (Wagner et al,
1997), MMTV-Neu (Muller et al, 1988), LSL-KrasG12D [12] and
Pdx1-Cre [13] mice have all been previously described. For
mammary gland experiments, female mice were bred at 7 weeks
and doxycycline feed was administered from date of litter birth.
Litters were nursed for 3 weeks to induce WAP promoter activity.
Parous mice monitored weekly for tumor formation by physical
palpation. See Table S1 for genotyping information on CAGs-
LSL-rtTA3 and CAGs-LSL-RIK strains.
Ethics statement
Production of mice and all treatments described were approved
by the Institutional Animal Care and Use Committee (IACUC) at
McGill University (Montreal, Canada) or Memorial Sloan
Kettering Cancer Center (NY) under protocol numbers: 2001–
4751 (McGill), 11-06-012, 11-06-015 and 12-04-006 (MSKCC).
Treatments
Doxycycline was administered via food pellets (625 mg/kg)
(Harlan Teklad). Adenovirus expressing Cre recombinase (Ade-
noCre) was purchased from The University of Iowa Gene transfer
Core. For adenoviral delivery to the liver: 56108 PFU AdenoCre/
mouse was injected intravenously via the tail vein. For adenoviral
delivery to the lung: 6–10 week-old mice were anesthetized by i.p.
injection of ketamine 80 mg/kg, xylazine 10 mg/kg [11] and
treated once by intratracheal instillation of 56106 PFU Ade-
noCre/mouse. Three months following AdenoCre treatment,
lungs were collected, fixed and analyzed by immunofluorescence
or immunohistochemistry.
Protein and RNA analysis
Protein lysates were prepared in RIPA buffer and quantified by
Lowry assay (BioRad). Western blots were probed with antibodies
against: TetR (rtTA3) (1:1000, mouse monoclonal Clone 9G9,
Clontech #631131), GFP (1:2000, chicken polyclonal, Abcam
#ab13970), tRFP (mKate2) (1:2000, rabbit polyclonal, Evrogen
#B00201) and b-Actin-HRP (1:5000, mouse monoclonal AC15
clone, Sigma #A3854). RNA was prepared from sorted cells by
Trizol extraction and column purification. cDNA was prepared
from 1 mg total RNA using Taqman reverse transcription kit
(Applied Biosystems, #N808-0234) with random hexamers.
Quantitative PCR detection was performed using SYBR green
reagents (Applied Biosystems) using primers specific to rtTA3: F:
59-CAATGGTGTCGGTATCGAAG-39, R: 59-CTTGTTCT-
TCACGTGCCAGT-39; mKate2: F: GGTGAGCGAGCTGA-
TTAAGG-39 and R: 59-TTTTGCTGCCGTACATGAAG-39;
and GFP: F: 59-ATCGACTTCAAGGAGGACGGCA-39 and R:
59-CGTTCTTCTGCTTGTCGGCCAT-39.
Immunophenotyping
Immunostaining and FACS analysis for blood lineages were
performed as previously described [22]. Briefly, single cell
suspensions from whole bone marrow, spleen and thymus were
immunostained for CD45.2 (APC-conjugate, BD #559864) and
cell lineage markers: Gr1 (Pacific blue, BioLegend #108430),
CD19 (Pacific Blue, BioLegend #115526) or Thy1 (Pacific blue,
BioLegend #105324) and the percentage of GFP and/or mKate2
expressing cells were calculated within these specific lineages
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populations. Data was collected on an LSR-II flow cytometer (BD
BioSciences) and analyzed using FlowJo software (Tree Star).
Immunohistochemistry
Tissue, fixed in 10% neutral buffered formalin for 24 hours, was
embedded in paraffin and sectioned by IDEXX RADIL
(Columbia, MO). Sections were rehydrated and unmasked
(antigen retrieval) by heat treatment for 5 mins in a pressure
cooker in 10 mM Tris/1 mM EDTA buffer (pH 9) containing
0.05% Tween 20. For immunohistochemistry, sections were
treated with 3% H2O2 for 10 mins and blocked in TBS containing
1% BSA. For immunofluorescence, sections were not treated with
peroxidase. Primary antibodies, incubated at 4C overnight in
blocking buffer, were: chicken anti-GFP (1:500,#ab13970), rabbit
anti-tRFP (1:2000, Evrogen,#AB232) and rabbit anti-ki67 (1:100,
Sp6 clone, Abcam #ab16667). For immunohistochemistry,
sections were incubated with anti-rabbit ImmPRESS reagent
(Vector Laboratories, #MP7401) and developed using ImmPACT
DAB (Vector Laboratories, #SK4105) according to the manu-
facturer instructions. For immunofluorescent stains, secondary
antibodies were applied for 1 hour at room temp in TBS in the
dark, washed twice with TBS, counterstained for 5 mins with
DAPI and mounted in ProLong Gold (Life Technologies,
#P36930). Secondary antibodies used were: anti-chicken 488
(1:500, DyLight IgG, #ab96947) and anti-rabbit 568 (1:500,
Molecular Probes, #a11036). Images of fluorescent and IHC
stained sections were acquired on a Zeiss Axioscope Imager Z.1
using a 10x (Zeiss NA 0.3) or 20x (Zeiss NA 0.17) objective and an
ORCA/ER CCD camera (Hamamatsu Photonics, Hamamatsu,
Japan). Raw.tif files were processed using Photoshop CS5 software
(Adobe Systems Inc., San Jose, CA) to adjust levels and/or apply
false coloring.
Supporting Information
Figure S1 Targeting CAGs-LSL-rtTA3 to the Rosa26
locus. A. Schematic of the Rosa26 locus before and after
recombination of the CAGs-LSL-rtTA3 or CAGs-LSL-RIK targeting
vector. Key restriction sites used for clone identification by
Southern blot are indicated. Sizes of each predicted fragment are
also shown and a solid black line highlights the position of the
Southern probe. B. Southern blot images showing identification of
Y1 (2.3 kb band) and D34 (4.8 kb band) clones, following EcoRV/
BglII and EcoRI digests, respectively. C. Fluorescence in situ
hybridization on a metaphase spread from D34 ES cells using the
CAGs-LSL-RIK fragment as a probe, showing homozygous
targeting of CAGs-LSL-RIK to Chromosome 6.
(TIF)
Figure S2 GFP induction following Adenoviral Cre
transduction in targeted Y1 and D34 ESCs. Y1 and D34
ESCs carrying TG-Ren.713 at the col1a1 locus were transduced
with adenovirus expressing Cre (Cre, green line) or not transduced
(no Cre, black line), treated with doxycycline (1 ug/ml) for 2 days
and analyzed by flow cytometry. Graphs represent bulk popula-
tion of transduced cells (not single clones). Bulk populations were
single cell cloned to assess the uniformity of GFP induction in the
presence of constitutive rtTA3 expression (see Fig. 1B).
(TIF)
Figure S3 GFP induction and mKate2 expression in
large intestine and liver. Immunofluorescence stains for GFP
and mKate2 in the large intestine and liver of ‘no rtTA’, R26-rtTA,
CAGs-rtTA3 and CAGs-RIK mice following 1 week of doxycycline
treatment. All rtTA strains show strong GFP induction in large
intestine (A), but only CAGs-rtTA3 and CAGs-RIK show robust and
uniform GFP expression (and mKate2 for RIK) in the liver tissue
(B).
(TIF)
Figure S4 Mosaic mKate2 expression in a proportion of
lung adenomas. Immunohistochemical stains for mKate2 and
Ki67 in lung sections of double transgenic mice (CAGs-LSL-
RIK;LSL-KrasG12D) treated with intratracheal Adenoviral Cre
(AdenoCre) or vehicle (Tris-HCl). 12 weeks following Cre delivery
LSL-KrasG12D mice show small, moderately proliferative
adenomas. Some adenomas show uniform mKate2 staining (top
panel of ‘AdenoCre’), while a subset showed both positive and
negative mKate2 cells (arrows) suggesting Cre-driven activated
KrasG12D but not rtTA3-IRES-mKate2. Adenoma area highlight-
ed by dotted line.
(TIF)
Table S1 Genotyping primers. Primer sequences and
expected PCR product sizes for genotyping Rosa26-targeted
CAGs-rtTA3 strains.
(DOCX)
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